North American Neuroendocrine Tumor Society is located in Albany, NY. The organization was established in 2007. According to its NTEE Classification (H12) the organization is classified as: Fund Raising & Fund Distribution, under the broad grouping of Medical Research and related organizations. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. North American Neuroendocrine Tumor Society is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2021, North American Neuroendocrine Tumor Society generated $777.6k in total revenue. The organization has seen a slow decline revenue. Over the past 7 years, revenues have fallen by an average of (0.2%) each year. All expenses for the organization totaled $490.3k during the year ending 12/2021. As we would expect to see with falling revenues, expenses have declined by (3.6%) per year over the past 7 years. You can explore the organizations financials more deeply in the financial statements section below.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2021
Describe the Organization's Mission:
Part 3 - Line 1
TO IMPROVE NEUROENDOCRINE TUMOR DISEASE MANAGEMENT THROUGH INCREASED RESEARCH AND EDUCATIONAL OPPORTUNITIES
Describe the Organization's Program Activity:
Part 3 - Line 4a
CONTINUING MEDICAL EDUCATION. PREVIOUSLY CONSIDERED A RARE DISEASE, NEUROENDOCRINE TUMORS HAVE NOW BEEN WELL DOCUMENTED AND DATA SUGGESTS THAT THE DIAGNOSED INCIDENCE IS INCREASING.
ANNUAL SYMPOSIUM FOR NEUROENDOCRINE TUMOR RESEARCH
Name (title) | Role | Hours | Compensation |
---|---|---|---|
Pamela Kunz Vice President | OfficerTrustee | 4 | $0 |
Jonathan Strosberg President | OfficerTrustee | 4 | $0 |
Jennifer Chan Treasurer | OfficerTrustee | 4 | $0 |
Thorvardur Halfdanarson Secretary | OfficerTrustee | 4 | $0 |
Jaydira Del Rivero Director | Trustee | 2 | $0 |
Simron Singh Director | Trustee | 2 | $0 |
Statement of Revenue | |
---|---|
Federated campaigns | $0 |
Membership dues | $42,760 |
Fundraising events | $0 |
Related organizations | $0 |
Government grants | $0 |
All other contributions, gifts, grants, and similar amounts not included above | $479,558 |
Noncash contributions included in lines 1a–1f | $0 |
Total Revenue from Contributions, Gifts, Grants & Similar | $522,318 |
Total Program Service Revenue | $253,582 |
Investment income | $1,691 |
Tax Exempt Bond Proceeds | $0 |
Royalties | $0 |
Net Rental Income | $0 |
Net Gain/Loss on Asset Sales | $0 |
Net Income from Fundraising Events | $0 |
Net Income from Gaming Activities | $0 |
Net Income from Sales of Inventory | $0 |
Miscellaneous Revenue | $0 |
Total Revenue | $777,591 |
Statement of Expenses | |
---|---|
Grants and other assistance to domestic organizations and domestic governments. | $0 |
Grants and other assistance to domestic individuals. | $0 |
Grants and other assistance to Foreign Orgs/Individuals | $0 |
Benefits paid to or for members | $0 |
Compensation of current officers, directors, key employees. | $0 |
Compensation of current officers, directors, key employees. | $0 |
Compensation to disqualified persons | $0 |
Other salaries and wages | $0 |
Pension plan accruals and contributions | $0 |
Other employee benefits | $0 |
Payroll taxes | $0 |
Fees for services: Management | $165,000 |
Fees for services: Legal | $398 |
Fees for services: Accounting | $5,000 |
Fees for services: Lobbying | $0 |
Fees for services: Fundraising | $0 |
Fees for services: Investment Management | $0 |
Fees for services: Other | $0 |
Advertising and promotion | $0 |
Office expenses | $1,314 |
Information technology | $0 |
Royalties | $0 |
Occupancy | $3,300 |
Travel | $0 |
Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
Conferences, conventions, and meetings | $186,950 |
Interest | $0 |
Payments to affiliates | $0 |
Depreciation, depletion, and amortization | $0 |
Insurance | $5,333 |
All other expenses | $19,394 |
Total functional expenses | $490,327 |
Balance Sheet | |
---|---|
Cash—non-interest-bearing | $1,567,260 |
Savings and temporary cash investments | $253,692 |
Pledges and grants receivable | $0 |
Accounts receivable, net | $9,475 |
Loans from Officers, Directors, or Controlling Persons | $0 |
Loans from Disqualified Persons | $0 |
Notes and loans receivable | $0 |
Inventories for sale or use | $0 |
Prepaid expenses and deferred charges | $50,000 |
Net Land, buildings, and equipment | $0 |
Investments—publicly traded securities | $0 |
Investments—other securities | $0 |
Investments—program-related | $0 |
Intangible assets | $0 |
Other assets | $0 |
Total assets | $1,880,427 |
Accounts payable and accrued expenses | $8,521 |
Grants payable | $0 |
Deferred revenue | $269,000 |
Tax-exempt bond liabilities | $0 |
Escrow or custodial account liability | $0 |
Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
Secured mortgages and notes payable | $0 |
Unsecured mortgages and notes payable | $0 |
Other liabilities | $0 |
Total liabilities | $277,521 |
Net assets without donor restrictions | $1,602,906 |
Net assets with donor restrictions | $0 |
Capital stock or trust principal, or current funds | $0 |
Paid-in or capital surplus, or land, building, or equipment fund | $0 |
Retained earnings, endowment, accumulated income, or other funds | $0 |
Total liabilities and net assets/fund balances | $1,880,427 |
Over the last fiscal year, North American Neuroendocrine Tumor Society has awarded $200,000 in support to 2 organizations.
Grant Recipient | Amount |
---|---|
Baltimore, MD PURPOSE: Research Funding | $100,000 |
UT MD ANDERSON CANCER CENTER PURPOSE: Research Funding | $100,000 |
Over the last fiscal year, we have identified 2 grants that North American Neuroendocrine Tumor Society has recieved totaling $100,100.
Awarding Organization | Amount |
---|---|
Neuroendocrine Tumor Research Foundation Boston, MA PURPOSE: RESEARCH | $100,000 |
Rosewood Foundation Dallas, TX PURPOSE: GENERAL USE | $100 |
Organization Name | Assets | Revenue |
---|---|---|
Pan-Massachusetts Challenge Inc Needham, MA | $4,238,156 | $66,009,480 |
Health Effects Institute Boston, MA | $12,526,721 | $12,481,645 |
The Association For Frontotemporal Degeneration King Of Prussia, PA | $44,796,969 | $12,057,958 |
Childrens Oncology Group Foundation Philadelphia, PA | $22,837,173 | $7,487,855 |
Hope For Depression Research Foundation New York, NY | $59,831,359 | $6,866,948 |
Israel Cancer Research Fund Inc New York, NY | $17,015,756 | $7,146,502 |
Life Science Cares Inc Cambridge, MA | $8,104,702 | $8,289,428 |
Haymakers For Hope Inc Wellesley, MA | $644,411 | $4,070,620 |
Fox Chase Cancer Center Foundation Philadelphia, PA | $63,333,365 | $6,307,847 |
The Progeria Research Foundation Inc Peabody, MA | $53,690,802 | $49,219,762 |
Improvecarenow Inc Essex, VT | $802,029 | $3,120,134 |
Dubai Harvard Foundation For Medical Research Inc Boston, MA | $15,096,309 | $431,547 |